A Study of RX108 in Patients With Locally Advanced or Metastatic Solid Tumors
Clinical trial NCT03646071 · UNKNOWN
Trial details
- NCT number
- NCT03646071
- Sponsor
- NeuPharma, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-01
- Primary completion
- 2023-08-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.